HST Global Inc. HSTC Archives

MondayDec 29, 2008 6:11 am

HST Global, Inc. (HSTC.OB) and EBITDA Capital are Focused on Attaining Success Together through Strategic Alliance

Earlier this year, HST Global announced that it contracted EBITDA Capital LLC of Newport Beach California and its group of associates to join HST-Global’s efforts in working toward an overall corporate strategy. The company also announced Former United States Congressman Bill Sarpalius, the President and CEO of Advantage Associates International, has been given the role of interfacing with the political community in Washington DC. Mr. Sarpalius said, “We are excited to be in a position to raise the awareness of both the public and members of the government about HST’s treatment solution. The opportunity of bringing a treatment for late…

TuesdayDec 23, 2008 7:13 am

HST Global, Inc. (HSTC.OB) has Big Plans for Next year

Alternative cancer treatments have been growing in acceptance worldwide, positioning HST Global perfectly to launch a wholly owned division focused on opening a new brand of Cancer Treatment Centers. While HST Global continues to look for in-licensing pre-clinical drug candidates, this strategy will allow the company to meet the needs of individuals that face cancer treatments. Ronald Howell, President and CEO of HST Global, Inc. stated earlier in a press release, “There is a growing population of individuals experiencing the lack of available alternatives in treating late stage cancer. We have been working with a number of highly visible Physicians…

FridayDec 19, 2008 10:02 am

HST Global, Inc. (HSTC.OB) Strengthens Scientific Board with New Member

HST Global, Inc. announced earlier this month that Dr. Kyl Smith has joined its Scientific Board. Much of Dr. Smith’s visibility has been earned in the world of natural medicine. He is a noted researcher, inventor, lecturer, author and scientist, and is known as the inventor of Focus Factor®, the number-one selling brain support product in North America for the last seven years. Dr. Kyl's passion is teaching doctors how to use nutritional therapies to improve cognitive function. He has been featured on numerous radio and television programs across the country, is the author of the acclaimed Brighter Mind® book…

ThursdayDec 18, 2008 10:34 am

HST Global, Inc. (HSTC.OB) is “One to Watch”

HST Global, Inc. is a development-stage biotechnology company committed to acquiring, developing and commercializing innovative products to enhance cancer care. The company determines to acquire proprietary rights to these products, fund their R&D, and bring the products to market. Since HST’s inception, they have focused their efforts and resources primarily on Salicinium, a clinical stage drug candidate, as well as raising capital and recruiting personnel. The company’s focus is on in-licensing and further advancing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer. Although the cost of licensing drug candidates that have…

Site Search

Company Search

Tag: HST Global Inc. HSTC

HST Global, Inc. (HSTC.OB) and EBITDA Capital are Focused on Attaining Success Together through Strategic Alliance

HST Global, Inc. (HSTC.OB) has Big Plans for Next year

HST Global, Inc. (HSTC.OB) Strengthens Scientific Board with New Member

HST Global, Inc. (HSTC.OB) is “One to Watch”

Market Basics

Newsletter Publishers

Public Companies